By continuing to grow in response to our clients’ needs, the members of BCA Advanced Therapies Network offer a wide portfolio of standardized, well-defined biomaterials with a comprehensive Certificate of Analysis.

A full and comprehensive list of products are now available from one single, global provider with various attributes unique to the expertise, experience, and capacities of each individual member and site throughout the country.


A diverse portfolio of standardized blood and tissue-derived biomaterials and cellular populations for use in research, product development and clinical products.

Our Products Include

Leukoreduction System Chambers:

Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes, and are a vital source of Viable Human Peripheral Blood Mononuclear Cells, T cells, and could replace standard buffy coat preparations for research applications.